Bumper Offer - Urjas oil Just @ Rs. 1
Rantidine (Cipla) is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Acidity, Peptic Ulcer, Heartburn. The alternative uses of Rantidine (Cipla) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Rantidine (Cipla). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Rantidine (Cipla) can also lead to other problems, which have been listed below. Usually, these side effects of Rantidine (Cipla) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Rantidine (Cipla)'s effect during pregnancy is Safe and Safe while nursing. It is important to know if Rantidine (Cipla) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rantidine (Cipla) related warnings section.
Other contraindications of Rantidine (Cipla) have been discussed in the sections ahead.
Drug reaction of Rantidine (Cipla) with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Rantidine (Cipla), it is important to know that it is safe while driving, and is habit-forming.
Rantidine (Cipla) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Rantidine (Cipla) is used -
Severe
Moderate
Mild
Is the use of Rantidine (Cipla) safe for pregnant women?
There are no side effects of Rantidine (Cipla) in pregnant women.
Is the use of Rantidine (Cipla) safe during breastfeeding?
Rantidine (Cipla) is safe for breastfeeding women.
What is the effect of Rantidine (Cipla) on the Kidneys?
Very few cases of side effects of Rantidine (Cipla) on kidney have been reported.
What is the effect of Rantidine (Cipla) on the Liver?
Rantidine (Cipla) is rarely harmful for the liver.
What is the effect of Rantidine (Cipla) on the Heart?
Using Rantidine (Cipla) does not have any harmful effects on the heart.
Rantidine (Cipla) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rantidine (Cipla) unless your doctor advises you to do so -
Is this Rantidine (Cipla) habit forming or addictive?
Rantidine (Cipla) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Rantidine (Cipla) since it does not cause drowsiness.
Is it safe?
Rantidine (Cipla) is safe as it does not bear any side effects.
Is it able to treat mental disorders?
No, Rantidine (Cipla) cannot treat any kind of mental disorder.
Interaction between Food and Rantidine (Cipla)
Information is not available on the interaction of any foods with Rantidine (Cipla), due to a lack of research on this.
Interaction between Alcohol and Rantidine (Cipla)
Taking Rantidine (Cipla) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zantac® (ranitidine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 650
